首页> 外文期刊>Biochemistry >Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.
【24h】

Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.

机译:在具有多重耐药性的HL60 / VCR人急性髓性白血病细胞系中鉴定和鉴定MDR1启动子增强因子1(MEF1)。

获取原文
获取原文并翻译 | 示例
           

摘要

In this report, the molecular mechanisms involved in the overexpression of MDR1 mRNA in the multidrug resistant variant of the HL60 human acute myeloid leukemia cell line, HL60/VCR, were investigated. RT-PCR and nuclear run-on assays revealed that the expression of MDR1 mRNA is regulated by increased transcriptional initiation in HL60/VCR cells. Transient transfections with a 241 bp MDR1 promoter (spanning the -198 to +43 region) DNA fragment/pGL3-basic plasmid construct resulted in about 6-fold increased luciferase activity in HL60/VCR but not in HL60 cells. Moreover, ds CAAT-oligomer from the MDR1 promoter cloned upstream of the SV-40 promoter in the pGL3-promoter plasmid caused about a 7-fold increase in luciferase activity compared with plasmid constructs containing CAAT-deleted, GC-box, and nonspecific oligomers in HL60/VCR transfectants. These results were confirmed by transfecting HL60/VCR cells with the pGL3-basic plasmid containing a 237 bp mutated MDR1 proximal promoter lacking the CAAT sequence in which no change in luciferase activity was observed. However, a 5-6-fold increase in luciferase activity was measured in these cells when transfected with the wt MDR1 promoter DNA/pGL3-basic plasmid constructs. These results show that the CAAT-region is involved in upregulating the MDR1 promoter in HL60/VCR cells. A nuclear factor binding to the CAAT-region of the MDR1 promoter specifically was detected in electrophoretic mobility shift assays (EMSAs) in HL60/VCR but not in HL60 extracts. Two MDR1 promoter-associated polypeptides with molecular masses of about 130 and 162 kDa were identified in HL60/VCR cells by electroelution, specific DNA-affinity chromatography, and silver staining. Interestingly, cross-linking and Southwestern analysis indicate that only the 130 kDa protein, which we refer to as MDR1-promoter enhancing factor 1 (MEF1), has a strong DNA-binding ability, interacting with the 5'-GTCAATCC-3' element of the MDR1 promoter, as determined by DNase I protection assay. These data reveal that MEF1 upregulates the MDR1 promoter activity.
机译:在本报告中,研究了HL60人急性髓细胞白血病细胞株HL60 / VCR的多药耐药变体中MDR1 mRNA过表达的分子机制。 RT-PCR和核运行分析表明,MDR1 mRNA的表达受HL60 / VCR细胞中转录起始增加的调节。用241 bp MDR1启动子(跨-198至+43区)DNA片段/ pGL3-碱性质粒构建体进行瞬时转染,可使HL60 / VCR中的萤光素酶活性提高约6倍,但在HL60细胞中则没有。此外,与克隆含有CAAT缺失,GC-box和非特异性寡聚体的质粒构建体相比,来自克隆于pGL3启动子质粒SV-40启动子上游MDR1启动子的ds CAAT寡聚体导致萤光素酶活性提高了约7倍。在HL60 / VCR转染子中。通过用含有237 bp突变的MDR1近端启动子的pGL3碱性质粒转染HL60 / VCR细胞来证实这些结果,该启动子缺少CAAT序列,在该序列中未观察到荧光素酶活性的变化。但是,当用wt MDR1启动子DNA / pGL3-碱性质粒构建体转染时,在这些细胞中测得的萤光素酶活性增加了5-6倍。这些结果表明,CAAT区参与了HL60 / VCR细胞中MDR1启动子的上调。在HL60 / VCR中的电泳迁移率变动分析(EMSA)中检测到了与MDR1启动子的CAAT区结合的核因子,而在HL60提取物中未检测到。通过电洗脱,特异性DNA亲和层析和银染在HL60 / VCR细胞中鉴定出了两种分子量分别约为130和162 kDa的MDR1启动子相关多肽。有趣的是,交联和西南分析表明,只有130 kDa蛋白(我们称为MDR1启动子增强因子1(MEF1))具有很强的DNA结合能力,与5'-GTCAATCC-3'元素相互作用通过DNase I保护试验确定MDR1启动子的活性。这些数据表明,MEF1上调了MDR1启动子的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号